|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q55300102
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010725.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q55300102
|
|
024
|
|
|
‡a
0000-0002-6339-5738
‡2
orcid
|
|
024
|
|
|
‡a
8696031300
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q55300102
|
|
100
|
0 |
|
‡a
Maurizio Leone
‡9
ast
‡9
es
‡9
sl
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Maurizio Leone
‡c
researcher (ORCID 0000-0002-6339-5738)
‡9
en
|
|
400
|
0 |
|
‡a
Maurizio Leone
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's A case of successful pregnancy in a woman with Friedreich ataxia
|
|
670
|
|
|
‡a
Author's A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement
|
|
670
|
|
|
‡a
Author's A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy
|
|
670
|
|
|
‡a
Author's A survival analysis of 155 cases of progressive muscular atrophy
|
|
670
|
|
|
‡a
Author's A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population
|
|
670
|
|
|
‡a
Author's Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database
|
|
670
|
|
|
‡a
Author's Alcohol use is a risk factor for a first generalized tonic-clonic seizure. The ALC.E.
|
|
670
|
|
|
‡a
Author's Alcohol use is a risk factor for a first generalized tonic-clonic seizure. The ALC.E. (Alcohol and Epilepsy) Study Group.
|
|
670
|
|
|
‡a
Author's Alcohol withdrawal syndrome: mechanisms, manifestations, and management.
|
|
670
|
|
|
‡a
Author's Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis.
|
|
670
|
|
|
‡a
Author's Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
|
|
670
|
|
|
‡a
Author's Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure
|
|
670
|
|
|
‡a
Author's Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
|
|
670
|
|
|
‡a
Author's Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects
|
|
670
|
|
|
‡a
Author's Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population
|
|
670
|
|
|
‡a
Author's Ataxia clinical rating scale in Friedreich disease
|
|
670
|
|
|
‡a
Author's B-mode transorbital ultrasononography for the diagnosis of acute optic neuritis. A systematic review
|
|
670
|
|
|
‡a
Author's Basic and advanced imaging of a case of Balò's concentric sclerosis
|
|
670
|
|
|
‡a
Author's Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases.
|
|
670
|
|
|
‡a
Author's CD45 and multiple sclerosis: the exon 4 C77G polymorphism
|
|
670
|
|
|
‡a
Author's CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers
|
|
670
|
|
|
‡a
Author's Cerebral venous thrombosis: a retrospective multicentre study of 48 patients
|
|
670
|
|
|
‡a
Author's Cerebrospinal fluid analysis and the determination of oligoclonal bands.
|
|
670
|
|
|
‡a
Author's Chronic alcohol use and first symptomatic epileptic seizures
|
|
670
|
|
|
‡a
Author's Chronic cerebrospinal venous insufficiency is not associated with chronic venous disorders: A case–control study
|
|
670
|
|
|
‡a
Author's Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study
|
|
670
|
|
|
‡a
Author's Comorbidity between CIDP and diabetes mellitus: only a matter of chance?
|
|
670
|
|
|
‡a
Author's Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
|
|
670
|
|
|
‡a
Author's Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution?
|
|
670
|
|
|
‡a
Author's Crowned dens syndrome in an elderly man
|
|
670
|
|
|
‡a
Author's Defective T cell Fas function in patients with multiple sclerosis
|
|
670
|
|
|
‡a
Author's Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases
|
|
670
|
|
|
‡a
Author's Disability and quality of life in hereditary ataxias: a self-administered postal questionnaire
|
|
670
|
|
|
‡a
Author's EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic
|
|
670
|
|
|
‡a
Author's Early symptom progression rate is related to ALS outcome: a prospective population-based study
|
|
670
|
|
|
‡a
Author's Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres
|
|
670
|
|
|
‡a
Author's Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application
|
|
670
|
|
|
‡a
Author's EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.
|
|
670
|
|
|
‡a
Author's EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.
|
|
670
|
|
|
‡a
Author's Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy
|
|
670
|
|
|
‡a
Author's Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
|
|
670
|
|
|
‡a
Author's Epilepsy and quality of life in adults: a review of instruments
|
|
670
|
|
|
‡a
Author's External validation of a prognostic model for seizure recurrence following a first unprovoked seizure and implications for driving
|
|
670
|
|
|
‡a
Author's Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study
|
|
670
|
|
|
‡a
Author's Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis
|
|
670
|
|
|
‡a
Author's Familial effects on the clinical course of multiple sclerosis
|
|
670
|
|
|
‡a
Author's Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy
|
|
670
|
|
|
‡a
Author's Follow-up of nerve conduction in chronic uremic patients during hemodialysis
|
|
670
|
|
|
‡a
Author's Friedreich's ataxia: a descriptive epidemiological study in an Italian population
|
|
670
|
|
|
‡a
Author's Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis
|
|
670
|
|
|
‡a
Author's Gamma-hydroxybutyrate
|
|
670
|
|
|
‡a
Author's Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal
|
|
670
|
|
|
‡a
Author's Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis
|
|
670
|
|
|
‡a
Author's Genetic association and altered gene expression of mir-155 in multiple sclerosis patients
|
|
670
|
|
|
‡a
Author's Genetic burden of common variants in progressive and bout-onset multiple sclerosis
|
|
670
|
|
|
‡a
Author's Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|
|
670
|
|
|
‡a
Author's Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
|
|
670
|
|
|
‡a
Author's Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis
|
|
670
|
|
|
‡a
Author's GSK3β genetic variability in patients with Multiple Sclerosis
|
|
670
|
|
|
‡a
Author's Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey
|
|
670
|
|
|
‡a
Author's Hereditary ataxias and paraplegias in Valle ďAosta, Italy: a study of prevalence and disability
|
|
670
|
|
|
‡a
Author's Hereditary motor and sensory neuropathies: A genetic and epidemiological study in the province of Turin, Italy
|
|
670
|
|
|
‡a
Author's HLA alleles modulate EBV viral load in multiple sclerosis.
|
|
670
|
|
|
‡a
Author's ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution
|
|
670
|
|
|
‡a
Author's Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
|
|
670
|
|
|
‡a
Author's Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
|
|
670
|
|
|
‡a
Author's Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population
|
|
670
|
|
|
‡a
Author's Influence of ancestral gender on transmission of familial amyotrophic lateral sclerosis
|
|
670
|
|
|
‡a
Author's Inter-coder agreement for ICD-9-CM coding of stroke
|
|
670
|
|
|
‡a
Author's Intra- and interobserver reliability of transorbital sonographic assessment of the optic nerve sheath diameter and optic nerve diameter in healthy adults
|
|
670
|
|
|
‡a
Author's Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis
|
|
670
|
|
|
‡a
Author's Isolated pons involvement in Posterior Reversible Encephalopathy Syndrome: Case report and review of the literature
|
|
670
|
|
|
‡a
Author's Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis
|
|
670
|
|
|
‡a
Author's Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans
|
|
670
|
|
|
‡a
Author's MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
|
|
670
|
|
|
‡a
Author's Mortality in patients with a first unprovoked seizure
|
|
670
|
|
|
‡a
Author's Motor neuron disease in the province of Turin, Italy, 1966–1980
|
|
670
|
|
|
‡a
Author's Motor neuron disease in the Province of Turin, Italy, 1971-1980.
|
|
670
|
|
|
‡a
Author's Multiple sclerosis progression is not associated with birth timing in Italy
|
|
670
|
|
|
‡a
Author's Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
|
|
670
|
|
|
‡a
Author's Myeloneuropathy due to copper deficiency: clinical and MRI findings after copper supplementation
|
|
670
|
|
|
‡a
Author's No evidence for a role of rareCYP27B1functional variations in multiple sclerosis
|
|
670
|
|
|
‡a
Author's No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis
|
|
670
|
|
|
‡a
Author's Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
|
|
670
|
|
|
‡a
Author's Overexpression of the Cytokine BAFF and Autoimmunity Risk
|
|
670
|
|
|
‡a
Author's Participation in medical decision-making: attitudes of Italians with multiple sclerosis
|
|
670
|
|
|
‡a
Author's Patterns of Mortality from Hereditary Ataxias in the United States, 1971 and 1973–1978
|
|
670
|
|
|
‡a
Author's Peripheral neuropathy caused by antiepileptic drugs. Neurophysiological study of the A delta and C fibers
|
|
670
|
|
|
‡a
Author's Pneumocephalus from Bronchopleural-Subarachnoid Fistula
|
|
670
|
|
|
‡a
Author's Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis
|
|
670
|
|
|
‡a
Author's Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces
|
|
670
|
|
|
‡a
Author's Predictors of attack severity and duration in multiple sclerosis: a prospective study.
|
|
670
|
|
|
‡a
Author's Prevalence of hereditary ataxias and paraplegias in the province of Torino, Italy
|
|
670
|
|
|
‡a
Author's Prevalence of Multiple Sclerosis in the Republic of Moldova
|
|
670
|
|
|
‡a
Author's Prognosis and clinical varieties of ALS disease
|
|
670
|
|
|
‡a
Author's Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males
|
|
670
|
|
|
‡a
Author's Progression of MRI abnormalities in herpes simplex encephalitis despite clinical improvement: natural history or disease progression?
|
|
670
|
|
|
‡a
Author's Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.
|
|
670
|
|
|
‡a
Author's Quantitative analysis of quadriceps muscle biopsy. Results in 7 definite and 45 possible carriers of Duchenne muscular dystrophy.
|
|
670
|
|
|
‡a
Author's Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
|
|
670
|
|
|
‡a
Author's Reliability of the modified Rankin Scale applied by telephone
|
|
670
|
|
|
‡a
Author's Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
|
|
670
|
|
|
‡a
Author's Risk factors for a first epileptic seizure after stroke: a case control study
|
|
670
|
|
|
‡a
Author's Risk factors for a first epileptic seizure symptomatic of brain tumour or brain vascular malformation. A case control study.
|
|
670
|
|
|
‡a
Author's Risk factors for a first generalized tonic-clonic seizure in adult life
|
|
670
|
|
|
‡a
Author's Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study
|
|
670
|
|
|
‡a
Author's Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
|
|
670
|
|
|
‡a
Author's Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management
|
|
670
|
|
|
‡a
Author's Sirkka-Liisa Leinonen
|
|
670
|
|
|
‡a
Author's SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis
|
|
670
|
|
|
‡a
Author's SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS)
|
|
670
|
|
|
‡a
Author's Stroke and transient ischaemic attack in 18 neurology departments from two Italian Regions: the SINPAC database
|
|
670
|
|
|
‡a
Author's The burden of multiple sclerosis variants in continental Italians and Sardinians
|
|
670
|
|
|
‡a
Author's The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain–Barré syndrome from chronic inflammatory demyelinating polyneuropathy
|
|
670
|
|
|
‡a
Author's The impact of osteopontin gene variations on multiple sclerosis development and progression
|
|
670
|
|
|
‡a
Author's The neurologist in the emergency department. An Italian nationwide epidemiological survey
|
|
670
|
|
|
‡a
Author's Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis
|
|
670
|
|
|
‡a
Author's Transorbital Sonography in Acute Optic Neuritis: A Case-Control Study
|
|
670
|
|
|
‡a
Author's Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial
|
|
670
|
|
|
‡a
Author's Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy
|
|
670
|
|
|
‡a
Author's Treatment policies for alcohol-related seizures: a survey of European neurologists
|
|
670
|
|
|
‡a
Author's Validity and Reliability of the Barthel Index Administered by Telephone
|
|
670
|
|
|
‡a
Author's Variations of the perforin gene in patients with multiple sclerosis
|
|
670
|
|
|
‡a
Author's Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals
|
|
909
|
|
|
‡a
(orcid) 0000000263395738
‡9
1
|
|
909
|
|
|
‡a
(scopus) 8696031300
‡9
1
|
|
912
|
|
|
‡a
geneticriskandaprimaryroleforcellmediatedimmunemechanismsinmultiplesclerosis
‡A
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
‡9
1
|
|
912
|
|
|
‡a
analysisofimmunerelatedlociidentifies48newsusceptibilityvariantsformultiplesclerosis
‡A
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
isolatedponsinvolvementinposteriorreversibleencephalopathysyndromecasereportandreviewoftheliterature
‡A
Isolated pons involvement in Posterior Reversible Encephalopathy Syndrome: Case report and review of the literature
‡9
1
|
|
919
|
|
|
‡a
inversecorrelationofgeneticriskscorewithageatonsetinboutonsetandprogressiveonsetmultiplesclerosis
‡A
Inverse correlation of genetic risk score with age at onset in bout-onset and progressive-onset multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
intraandinterobserverreliabilityoftransorbitalsonographicassessmentoftheopticnervesheathdiameterandopticnervediameterinhealthyadults
‡A
Intra- and interobserver reliability of transorbital sonographic assessment of the optic nerve sheath diameter and optic nerve diameter in healthy adults
‡9
1
|
|
919
|
|
|
‡a
intercoderagreementforicd9900codingofstroke
‡A
Inter-coder agreement for ICD-9-CM coding of stroke
‡9
1
|
|
919
|
|
|
‡a
influenceofancestralgenderontransmissionoffamilialamyotrophiclateralsclerosis
‡A
Influence of ancestral gender on transmission of familial amyotrophic lateral sclerosis
‡9
1
|
|
919
|
|
|
‡a
friedreichsataxiaadescriptiveepidemiologicalstudyinanitalianpopulation
‡A
Friedreich's ataxia: a descriptive epidemiological study in an Italian population
‡9
1
|
|
919
|
|
|
‡a
functionalvariationsmodulatingprkcaexpressionandalternativesplicingpredisposetomultiplesclerosis
‡A
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
gammahydroxybutyrate
‡A
Gamma-hydroxybutyrate
‡9
1
|
|
919
|
|
|
‡a
gammahydroxybutyrateghbforpreventionandtreatmentofalcoholwithdrawal
‡A
Gamma-hydroxybutyrate (GHB) for prevention and treatment of alcohol withdrawal
‡9
1
|
|
919
|
|
|
‡a
genderspecificinfluenceofthechromosome16chemokinegeneclusteronthesusceptibilitytomultiplesclerosis
‡A
Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis
‡9
1
|
|
919
|
|
|
‡a
geneticassociationandalteredgeneexpressionofmir155inmultiplesclerosispatients
‡A
Genetic association and altered gene expression of mir-155 in multiple sclerosis patients
‡9
1
|
|
919
|
|
|
‡a
geneticburdenofcommonvariantsinprogressiveandboutonsetmultiplesclerosis
‡A
Genetic burden of common variants in progressive and bout-onset multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
immunoproteasomelmp260hhvariantaltersmbpepitopegenerationandreducestherisktodevelopmultiplesclerosisinitalianfemalepopulation
‡A
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population
‡9
1
|
|
919
|
|
|
‡a
geneticvariantsaremajordeterminantsofcsfantibodylevelsinmultiplesclerosis
‡A
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
immediateantiepilepticdrugtreatmentversusplacebodeferredornotreatmentfor1unprovokedseizure
‡A
Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
‡9
1
|
|
919
|
|
|
‡a
growtharrestspecificgene6proteinconcentrationincerebrospinalfluidcorrelateswithrelapseseverityinmultiplesclerosis
‡A
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
idiopathicchronicinflammatorydemyelinatingpolyneuropathyanepidemiologicalstudyinitaly
‡A
Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy
‡9
1
|
|
919
|
|
|
‡a
gsk3βgeneticvariabilityinpatientswithmultiplesclerosis
‡A
GSK3β genetic variability in patients with Multiple Sclerosis
‡9
1
|
|
919
|
|
|
‡a
icosgenehaplotypescorrelatewithil10secretionandmultiplesclerosisevolution
‡A
ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution
‡9
1
|
|
919
|
|
|
‡a
guillainbarresyndromeaprospectivepopulationbasedincidenceandoutcomesurvey
‡A
Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey
‡9
1
|
|
919
|
|
|
‡a
hlaallelesmodulateebvviralloadinmultiplesclerosis
‡A
HLA alleles modulate EBV viral load in multiple sclerosis.
‡9
1
|
|
919
|
|
|
‡a
hereditaryataxiasandparaplegiasinvalledaostaitalyastudyofprevalenceanddisability
‡A
Hereditary ataxias and paraplegias in Valle ďAosta, Italy: a study of prevalence and disability
‡9
1
|
|
919
|
|
|
‡a
hereditarymotorandsensoryneuropathiesageneticandepidemiologicalstudyintheprovinceofturinitaly
‡A
Hereditary motor and sensory neuropathies: A genetic and epidemiological study in the province of Turin, Italy
‡9
1
|
|
919
|
|
|
‡a
caseofsuccessfulpregnancyinawomanwithfriedreichataxia
‡A
A case of successful pregnancy in a woman with Friedreich ataxia
‡9
1
|
|
919
|
|
|
‡a
reliabilitystudyofcolourdopplersonographyforthediagnosisofchroniccerebrospinalvenousinsufficiencyshowslowinterrateragreement
‡A
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement
‡9
1
|
|
919
|
|
|
‡a
sequencevariationinthemoggeneisinvolvedinmultiplesclerosissusceptibilityinitaly
‡A
A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy
‡9
1
|
|
919
|
|
|
‡a
survivalanalysisof155casesofprogressivemuscularatrophy
‡A
A survival analysis of 155 cases of progressive muscular atrophy
‡9
1
|
|
919
|
|
|
‡a
wholegenomescreenforlinkagedisequilibriuminmultiplesclerosisperformedinacontinentalitalianpopulation
‡A
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population
‡9
1
|
|
919
|
|
|
‡a
accuracyoftheicd9codesforidentifyingtiaandstrokeinanitalianautomateddatabase
‡A
Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database
‡9
1
|
|
919
|
|
|
‡a
alcoholuseisariskfactorfora1generalizedtonicclonicseizurethealce
‡A
Alcohol use is a risk factor for a first generalized tonic-clonic seizure. The ALC.E.
‡9
1
|
|
919
|
|
|
‡a
alcoholuseisariskfactorfora1generalizedtonicclonicseizurethealcealcoholandepilepsystudygroup
‡A
Alcohol use is a risk factor for a first generalized tonic-clonic seizure. The ALC.E. (Alcohol and Epilepsy) Study Group.
‡9
1
|
|
919
|
|
|
‡a
alcoholwithdrawalsyndromemechanismsmanifestationsandmanagement
‡A
Alcohol withdrawal syndrome: mechanisms, manifestations, and management.
‡9
1
|
|
919
|
|
|
‡a
analysisofgenespathwaysandnetworksinvolvedindiseaseseverityandageatonsetinprimaryprogressivemultiplesclerosis
‡A
Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis.
‡9
1
|
|
919
|
|
|
‡a
assessingsubjectivequalityoflifedomainsaftermultiplesclerosisdiagnosisdisclosure
‡A
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure
‡9
1
|
|
919
|
|
|
‡a
associationofgeneticmarkerswithcsfoligoclonalbandsinmultiplesclerosispatients
‡A
Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
‡9
1
|
|
919
|
|
|
‡a
associationofhlaclass1markerswithmultiplesclerosisintheitalianandukpopulationevidenceof2independentprotectiveeffects
‡A
Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects
‡9
1
|
|
919
|
|
|
‡a
associationofthecblbgenewithmultiplesclerosisnewevidencefromareplicationstudyinanitalianpopulation
‡A
Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population
‡9
1
|
|
919
|
|
|
‡a
ataxiaclinicalratingscaleinfriedreichdisease
‡A
Ataxia clinical rating scale in Friedreich disease
‡9
1
|
|
919
|
|
|
‡a
bmodetransorbitalultrasononographyforthediagnosisofacuteopticneuritisasystematicreview
‡A
B-mode transorbital ultrasononography for the diagnosis of acute optic neuritis. A systematic review
‡9
1
|
|
919
|
|
|
‡a
basicandadvancedimagingofacaseofbalosconcentricsclerosis
‡A
Basic and advanced imaging of a case of Balò's concentric sclerosis
‡9
1
|
|
919
|
|
|
‡a
vitamin500receptorvdrgenesnpsinfluencevdrexpressionandmodulateprotectionfrommultiplesclerosisinhladrb115positiveindividuals
‡A
Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals
‡9
1
|
|
919
|
|
|
‡a
variationsoftheperforingeneinpatientswithmultiplesclerosis
‡A
Variations of the perforin gene in patients with multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
validityandreliabilityofthebarthelindexadministeredbytelephone
‡A
Validity and Reliability of the Barthel Index Administered by Telephone
‡9
1
|
|
919
|
|
|
‡a
treatmentpoliciesforalcoholrelatedseizuresasurveyofeuropeanneurologists
‡A
Treatment policies for alcohol-related seizures: a survey of European neurologists
‡9
1
|
|
919
|
|
|
‡a
treatmentofthe1tonicclonicseizuredoesnotaffectlongtermremissionofepilepsy
‡A
Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy
‡9
1
|
|
919
|
|
|
‡a
treatmentof1tonicclonicseizuredoesnotaffectmortalitylongtermfollowupofarandomisedclinicaltrial
‡A
Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial
‡9
1
|
|
919
|
|
|
‡a
transorbitalsonographyinacuteopticneuritisacasecontrolstudy
‡A
Transorbital Sonography in Acute Optic Neuritis: A Case-Control Study
‡9
1
|
|
919
|
|
|
‡a
transorbitalsonographyandvisualoutcomeforthediagnosisandmonitoringofopticneuritis
‡A
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis
‡9
1
|
|
919
|
|
|
‡a
neurologistintheemergencydepartmentanitaliannationwideepidemiologicalsurvey
‡A
The neurologist in the emergency department. An Italian nationwide epidemiological survey
‡9
1
|
|
919
|
|
|
‡a
impactofosteopontingenevariationsonmultiplesclerosisdevelopmentandprogression
‡A
The impact of osteopontin gene variations on multiple sclerosis development and progression
‡9
1
|
|
919
|
|
|
‡a
expressionpatternofinflammatorymediatorsincerebrospinalfluiddifferentiatesguillainbarresyndromefromchronicinflammatorydemyelinatingpolyneuropathy
‡A
The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain–Barré syndrome from chronic inflammatory demyelinating polyneuropathy
‡9
1
|
|
919
|
|
|
‡a
burdenofmultiplesclerosisvariantsincontinentalitaliansandsardinians
‡A
The burden of multiple sclerosis variants in continental Italians and Sardinians
‡9
1
|
|
919
|
|
|
‡a
strokeandtransientischaemicattackin18neurologydepartmentsfrom2italianregionsthesinpacdatabase
‡A
Stroke and transient ischaemic attack in 18 neurology departments from two Italian Regions: the SINPAC database
‡9
1
|
|
919
|
|
|
‡a
sod1genemutationsinitalianpatientswithsporadicamyotrophiclateralsclerosisals
‡A
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS)
‡9
1
|
|
919
|
|
|
‡a
sod1genemutationsinitalianpatientswithsporadicamyotrophiclateralsclerosis
‡A
SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis
‡9
1
|
|
919
|
|
|
‡a
sirkkaliisaleinonen
‡A
Sirkka-Liisa Leinonen
‡9
1
|
|
919
|
|
|
‡a
seizuresinalcoholdependentpatientsepidemiologypathophysiologyandmanagement
‡A
Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management
‡9
1
|
|
919
|
|
|
‡a
roleofantiosteopontinantibodiesinmultiplesclerosisandexperimentalautoimmuneencephalomyelitis
‡A
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
‡9
1
|
|
919
|
|
|
‡a
riskofmultiplesclerosisfollowingclinicallyisolatedsyndromea4yearprospectivestudy
‡A
Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study
‡9
1
|
|
919
|
|
|
‡a
riskfactorsfora1generalizedtonicclonicseizureinadultlife
‡A
Risk factors for a first generalized tonic-clonic seizure in adult life
‡9
1
|
|
919
|
|
|
‡a
riskfactorsfora1epilepticseizuresymptomaticofbraintumourorbrainvascularmalformationacasecontrolstudy
‡A
Risk factors for a first epileptic seizure symptomatic of brain tumour or brain vascular malformation. A case control study.
‡9
1
|
|
919
|
|
|
‡a
riskfactorsfora1epilepticseizureafterstrokeacasecontrolstudy
‡A
Risk factors for a first epileptic seizure after stroke: a case control study
‡9
1
|
|
919
|
|
|
‡a
responsivenessofpatientreportedoutcomemeasuresinmultiplesclerosisrelapsestheremsstudy
‡A
Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
‡9
1
|
|
919
|
|
|
‡a
reliabilityofthemodifiedrankinscaleappliedbytelephone
‡A
Reliability of the modified Rankin Scale applied by telephone
‡9
1
|
|
919
|
|
|
‡a
quarterlyrepeatcyclesofonabotulinumtoxinainchronicmigrainepatientsthebenefitsoftheprolongedtreatmentonthecontinuousrespondersandqualityoflifeconversionrateinareallifesetting
‡A
Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
‡9
1
|
|
919
|
|
|
‡a
quantitativeanalysisofquadricepsmusclebiopsyresultsin7definiteand45possiblecarriersofduchennemusculardystrophy
‡A
Quantitative analysis of quadriceps muscle biopsy. Results in 7 definite and 45 possible carriers of Duchenne muscular dystrophy.
‡9
1
|
|
919
|
|
|
‡a
prolactinandprolactinreceptorgenepolymorphismsinmultiplesclerosisandsystemiclupuserythematosus
‡A
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.
‡9
1
|
|
919
|
|
|
‡a
progressionofmriabnormalitiesinherpessimplexencephalitisdespiteclinicalimprovementnaturalhistoryordiseaseprogression
‡A
Progression of MRI abnormalities in herpes simplex encephalitis despite clinical improvement: natural history or disease progression?
‡9
1
|
|
919
|
|
|
‡a
bovinespongiformencephalopathyandcreutzfeldtjakobdiseasefactsanduncertaintiesunderlyingthecausallinkbetweenanimalandhumandiseases
‡A
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases.
‡9
1
|
|
919
|
|
|
‡a
cd45andmultiplesclerosistheexon4c77gpolymorphism
‡A
CD45 and multiple sclerosis: the exon 4 C77G polymorphism
‡9
1
|
|
919
|
|
|
‡a
cd45andmultiplesclerosistheexon4c77gpolymorphismadditionalstudiesandmetaanalysisandnewmarkers
‡A
CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers
‡9
1
|
|
919
|
|
|
‡a
cerebralvenousthrombosisaretrospectivemulticentrestudyof48patients
‡A
Cerebral venous thrombosis: a retrospective multicentre study of 48 patients
‡9
1
|
|
919
|
|
|
‡a
cerebrospinalfluidanalysisandthedeterminationofoligoclonalbands
‡A
Cerebrospinal fluid analysis and the determination of oligoclonal bands.
‡9
1
|
|
919
|
|
|
‡a
chronicalcoholuseand1symptomaticepilepticseizures
‡A
Chronic alcohol use and first symptomatic epileptic seizures
‡9
1
|
|
919
|
|
|
‡a
chroniccerebrospinalvenousinsufficiencyisnotassociatedwithchronicvenousdisordersacasecontrolstudy
‡A
Chronic cerebrospinal venous insufficiency is not associated with chronic venous disorders: A case–control study
‡9
1
|
|
919
|
|
|
‡a
chroniccerebrospinalvenousinsufficiencyisnotassociatedwithmultiplesclerosisanditsseverityablindverifiedstudy
‡A
Chronic cerebrospinal venous insufficiency is not associated with multiple sclerosis and its severity: a blind-verified study
‡9
1
|
|
919
|
|
|
‡a
comorbiditybetweencidpanddiabetesmellitusonlyamatterofchance
‡A
Comorbidity between CIDP and diabetes mellitus: only a matter of chance?
‡9
1
|
|
919
|
|
|
‡a
conversionfromclinicallyisolatedsyndrometomultiplesclerosisalargemulticentrestudy
‡A
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
‡9
1
|
|
919
|
|
|
‡a
costconscioushighqualitycareandguidelinedevelopmenteducationastrangecontradictionorsimplesolution
‡A
Cost-conscious high-quality care and guideline development education: a strange contradiction or simple solution?
‡9
1
|
|
919
|
|
|
‡a
crowneddenssyndromeinanelderlyman
‡A
Crowned dens syndrome in an elderly man
‡9
1
|
|
919
|
|
|
‡a
defectivetcellfasfunctioninpatientswithmultiplesclerosis
‡A
Defective T cell Fas function in patients with multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
diagnosisandmanagementofmarchiafavabignamidiseaseareviewofctmriconfirmedcases
‡A
Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases
‡9
1
|
|
919
|
|
|
‡a
disabilityandqualityoflifeinhereditaryataxiasaselfadministeredpostalquestionnaire
‡A
Disability and quality of life in hereditary ataxias: a self-administered postal questionnaire
‡9
1
|
|
919
|
|
|
‡a
eanconsensusstatementformanagementofpatientswithneurologicaldiseasesduringthecovid19pandemic
‡A
EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic
‡9
1
|
|
919
|
|
|
‡a
earlysymptomprogressionrateisrelatedtoalsoutcomeaprospectivepopulationbasedstudy
‡A
Early symptom progression rate is related to ALS outcome: a prospective population-based study
‡9
1
|
|
919
|
|
|
‡a
effectoforganizationalfeaturesonpatientsatisfactionwithcareinitalianmultiplesclerosiscentres
‡A
Effect of organizational features on patient satisfaction with care in Italian multiple sclerosis centres
‡9
1
|
|
919
|
|
|
‡a
effectsofbotulinumtoxinonmigraineattackfeaturesinchronicmigrainea6monthopenlabelobservationstudythroughelectronicdiarysmartphoneapplication
‡A
Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application
‡9
1
|
|
919
|
|
|
‡a
efnsguidelineonthediagnosisandmanagementofalcoholrelatedseizuresreportofanefnstaskforce
‡A
EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.
‡9
1
|
|
919
|
|
|
‡a
efnsguidelinesfordiagnosistherapyandpreventionofwernickeencephalopathy
‡A
EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.
‡9
1
|
|
919
|
|
|
‡a
elevationofgas6proteinconcentrationincerebrospinalfluidofpatientswithchronicinflammatorydemyelinatingpolyneuropathy
‡A
Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy
‡9
1
|
|
919
|
|
|
‡a
elevationofgas6proteinconcentrationincerebrospinalfluidofpatientswithchronicinflammatorydemyelinatingpolyneuropathycidp
‡A
Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
‡9
1
|
|
919
|
|
|
‡a
epilepsyandqualityoflifeinadultsareviewofinstruments
‡A
Epilepsy and quality of life in adults: a review of instruments
‡9
1
|
|
919
|
|
|
‡a
externalvalidationofaprognosticmodelforseizurerecurrencefollowinga1unprovokedseizureandimplicationsfordriving
‡A
External validation of a prognostic model for seizure recurrence following a first unprovoked seizure and implications for driving
‡9
1
|
|
919
|
|
|
‡a
factorspredictingincompleterecoveryfromrelapsesinmultiplesclerosisaprospectivestudy
‡A
Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study
‡9
1
|
|
919
|
|
|
‡a
familialclusteringinitalianprogressiveonsetandboutonsetmultiplesclerosis
‡A
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
familialeffectsontheclinicalcourseofmultiplesclerosis
‡A
Familial effects on the clinical course of multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
fasmediatedtcellapoptosisisimpairedinpatientswithchronicinflammatorydemyelinatingpolyneuropathy
‡A
Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy
‡9
1
|
|
919
|
|
|
‡a
followupofnerveconductioninchronicuremicpatientsduringhemodialysis
‡A
Follow-up of nerve conduction in chronic uremic patients during hemodialysis
‡9
1
|
|
919
|
|
|
‡a
progranulingenevariabilityincreasestheriskforprimaryprogressivemultiplesclerosisinmales
‡A
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males
‡9
1
|
|
919
|
|
|
‡a
prognosisandclinicalvarietiesofalsdisease
‡A
Prognosis and clinical varieties of ALS disease
‡9
1
|
|
919
|
|
|
‡a
prevalenceofmultiplesclerosisintherepublicofmoldova
‡A
Prevalence of Multiple Sclerosis in the Republic of Moldova
‡9
1
|
|
919
|
|
|
‡a
prevalenceofhereditaryataxiasandparaplegiasintheprovinceoftorinoitaly
‡A
Prevalence of hereditary ataxias and paraplegias in the province of Torino, Italy
‡9
1
|
|
919
|
|
|
‡a
predictorsofattackseverityanddurationinmultiplesclerosisaprospectivestudy
‡A
Predictors of attack severity and duration in multiple sclerosis: a prospective study.
‡9
1
|
|
919
|
|
|
‡a
practicalrecommendationsfortheprocessofproposingplanningandwritinganeurologicalmanagementguidelinebyeantaskforces
‡A
Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces
‡9
1
|
|
919
|
|
|
‡a
polymorphismsinthegenescodingforironbindingandtransportingproteinsareassociatedwithdisabilityseverityandearlyprogressioninmultiplesclerosis
‡A
Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
pneumocephalusfrombronchopleuralsubarachnoidfistula
‡A
Pneumocephalus from Bronchopleural-Subarachnoid Fistula
‡9
1
|
|
919
|
|
|
‡a
peripheralneuropathycausedbyantiepilepticdrugsneurophysiologicalstudyoftheadeltaand100fibers
‡A
Peripheral neuropathy caused by antiepileptic drugs. Neurophysiological study of the A delta and C fibers
‡9
1
|
|
919
|
|
|
‡a
patternsofmortalityfromhereditaryataxiasintheunitedstates1971and1973
‡A
Patterns of Mortality from Hereditary Ataxias in the United States, 1971 and 1973–1978
‡9
1
|
|
919
|
|
|
‡a
participationinmedicaldecisionmakingattitudesofitalianswithmultiplesclerosis
‡A
Participation in medical decision-making: attitudes of Italians with multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
overexpressionofthecytokinebaffandautoimmunityrisk
‡A
Overexpression of the Cytokine BAFF and Autoimmunity Risk
‡9
1
|
|
919
|
|
|
‡a
osteopontingenehaplotypescorrelatewithmultiplesclerosisdevelopmentandprogression
‡A
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
‡9
1
|
|
919
|
|
|
‡a
noevidenceofassociationoftherarenssnprs35667974inifih1withmultiplesclerosis
‡A
No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
noevidenceforaroleofrarecyp27b1functionalvariationsinmultiplesclerosis
‡A
No evidence for a role of rareCYP27B1functional variations in multiple sclerosis
‡9
1
|
|
919
|
|
|
‡a
myeloneuropathyduetocopperdeficiencyclinicalandmrifindingsaftercoppersupplementation
‡A
Myeloneuropathy due to copper deficiency: clinical and MRI findings after copper supplementation
‡9
1
|
|
919
|
|
|
‡a
multiplesclerosisseverityscoreusingdisabilityanddiseasedurationtoratediseaseseverity
‡A
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
‡9
1
|
|
919
|
|
|
‡a
multiplesclerosisprogressionisnotassociatedwithbirthtiminginitaly
‡A
Multiple sclerosis progression is not associated with birth timing in Italy
‡9
1
|
|
919
|
|
|
‡a
motorneurondiseaseintheprovinceofturinitaly1971
‡A
Motor neuron disease in the Province of Turin, Italy, 1971-1980.
‡9
1
|
|
919
|
|
|
‡a
motorneurondiseaseintheprovinceofturinitaly1966
‡A
Motor neuron disease in the province of Turin, Italy, 1966–1980
‡9
1
|
|
919
|
|
|
‡a
mortalityinpatientswitha1unprovokedseizure
‡A
Mortality in patients with a first unprovoked seizure
‡9
1
|
|
919
|
|
|
‡a
1600ccl22intrathecallevelsinpatientswithmultiplesclerosis
‡A
MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
‡9
1
|
|
919
|
|
|
‡a
linkagedisequilibriumscreeningformultiplesclerosisimplicatesjag1andpou2af1assusceptibilitygenesineuropeans
‡A
Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans
‡9
1
|
|
919
|
|
|
‡a
lackofsupportforassociationbetweenthekif1brs10492972variantandmultiplesclerosis
‡A
Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis
‡9
1
|
|
943
|
|
|
‡a
197x
‡A
1978
‡9
1
|
|
943
|
|
|
‡a
198x
‡A
1980
‡9
2
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
PTBNP|247717
|
|
996
|
|
|
‡2
ISNI|0000000393336779
|
|
996
|
|
|
‡2
LC|n 2007183250
|
|
996
|
|
|
‡2
ISNI|0000000070022505
|
|
996
|
|
|
‡2
PLWABN|9810539658805606
|
|
996
|
|
|
‡2
BNF|17157445
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Leone, Maurizio Angelo.
‡2
NUKAT|n 2017144594
‡3
viafid
‡3
exact title: (1.00, 'efnsguidelinesfordiagnosistherapyandpreventionofwernickeencephalopathy', 'efnsguidelinesfordiagnosistherapyandpreventionofwernickeencephalopathy')
|
